Veterinary News and Research

RSS

New technology allows rapid detection of specific airborne viruses in the field

Researchers in South Korea have developed a technology that enables immediate detection of specific airborne viruses in the field.

10 Dec 2020

FDA approves first COVID-19 direct-to-consumer test

Today, the U.S. Food and Drug Administration authorized LabCorp's Pixel COVID-19 Test Home Collection Kit for use by any individual 18 years and older without a prescription.

9 Dec 2020

Study links insulin resistance and ozone exposure to interstitial lung disease

People with pre-diabetes or diabetes who live in ozone-polluted areas may have an increased risk for an irreversible disease with a high mortality rate.

9 Dec 2020

Virginia Tech researchers awarded NIH grant to develop Zika virus vaccine

Flaviviruses -- a group of viruses transmitted by ticks or mosquitoes -- infect an estimated 400 million people annually with diseases like yellow fever, Dengue fever, West Nile virus, and, most recently, Zika virus.

9 Dec 2020

People with Bartonella infection exhibit neuropsychiatric symptoms, skin lesions

Bartonella bacteria are increasingly recognized as an emerging infectious disease threat. A new study by North Carolina State University researchers has found additional instances of Bartonella infection in humans who exhibited neuropsychiatric symptoms, a subset of whom also had skin lesions.

8 Dec 2020

GlycoNet scientists secure up to $4 million US investment to advance regenerative medicine

GlycoNet scientists Drs. Robert Ben and Jason Acker, who are revolutionizing the cryopreservation of cells, tissues and organs for human and veterinary therapies, have secured a $2-million USD equity investment for PanTHERA CryoSolutions (PanTHERA), a Canadian biotechnology start-up that they co-founded.

8 Dec 2020

Researchers develop potential non-drug, non-surgical, long-acting therapy for glaucoma

Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery with a twice-a-year injection to control the buildup of pressure in the eye.

7 Dec 2020

FDA authorizes first COVID-19 test to detect COVID-19, influenza A and B

Today, the U.S. Food and Drug Administration authorized the first diagnostic test for at home collection of patient samples to detect both COVID-19 and influenza A and B (flu).

7 Dec 2020

Researchers develop wound-healing gel based on a substance produced by Trichoderma fungi

Researchers from the Department of Biochemistry of RUDN University developed a wound-healing gel based on a substance that is produced by Trichoderma fungi.

5 Dec 2020

Emergence of new zoonotic infections like SARS-CoV-2 is inevitable

A team of researchers at the ICAR-Indian Veterinary Research Institute explored the role of animals, the veterinary, and associated zoonotic links of SARS-CoV-2 and prevention and control strategies based on 'One Health' approaches. The research is published in the journal Veterinary Quarterly.

2 Dec 2020

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) - the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.

1 Dec 2020

Experimental vaccine protects cynomolgus macaques against Crimean-Congo hemorrhagic fever virus

An experimental vaccine developed in Europe to prevent infection by Crimean-Congo hemorrhagic fever virus (CCHFV) has protected cynomolgus macaques in a new collaborative study from National Institutes of Health scientists.

30 Nov 2020

FDA issues guidance on use of dry heat to support reuse of certain respirators

Today, the U.S. Food and Drug Administration issued guidance on the use of dry heat to help support the single-user reuse of certain particulate filtering facepiece respirators (FFRs), such as N95 respirators, by health care personnel when there is a limited supply of respirators during the COVID-19 public health emergency.

25 Nov 2020

Penn State researcher to study how vitamin D regulates host immunity to viral infection

Funding from the National Institutes of Health will enable a Penn State researcher to study whether vitamin D supplementation could help people ward off or reduce symptoms caused by COVID-19.

24 Nov 2020

Research provides key information on transmission, development of mutations in SARS-CoV-2 virus

In the COVID-19 pandemic, 57 million people have already been infected worldwide. In the search for vaccines and therapies, a precise understanding of the virus, its mutations, and transmission mechanisms are crucial.

24 Nov 2020

New technology can provide immunization against infectious diseases

A single-use, self-administered microneedle technology developed by UConn faculty to provide immunization against infectious diseases has recently been validated by preclinical research trials.

23 Nov 2020

Favorable clinical outcome for ivermectin in COVID-19 animal model

A team of researchers at the Institut Pasteur in France has found that ivermectin prevented clinical deterioration in infected animals. The drug also reduced the inflammatory cytokines, interleukin-6 and 10 (IL-6 and IL-10) in lung tissue, which leads to more favorable clinical outcomes in treated animals.

23 Nov 2020

FDA expands approved indication for influenza treatment to include post-exposure prevention

Today, the U.S. Food and Drug Administration expanded the approved indication for Xofluza (baloxavir marboxil) to include post-exposure prevention of influenza (flu) for patients 12 years of age and older after contact with an individual who has the flu.

23 Nov 2020

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.

23 Nov 2020

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.

23 Nov 2020

Veterinary News and Research

New technology allows rapid detection of specific airborne viruses in the field

FDA approves first COVID-19 direct-to-consumer test

Study links insulin resistance and ozone exposure to interstitial lung disease

Virginia Tech researchers awarded NIH grant to develop Zika virus vaccine

People with Bartonella infection exhibit neuropsychiatric symptoms, skin lesions

GlycoNet scientists secure up to $4 million US investment to advance regenerative medicine

Researchers develop potential non-drug, non-surgical, long-acting therapy for glaucoma

FDA authorizes first COVID-19 test to detect COVID-19, influenza A and B

Researchers develop wound-healing gel based on a substance produced by Trichoderma fungi

Emergence of new zoonotic infections like SARS-CoV-2 is inevitable

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Experimental vaccine protects cynomolgus macaques against Crimean-Congo hemorrhagic fever virus

FDA issues guidance on use of dry heat to support reuse of certain respirators

Penn State researcher to study how vitamin D regulates host immunity to viral infection

Research provides key information on transmission, development of mutations in SARS-CoV-2 virus

New technology can provide immunization against infectious diseases

Favorable clinical outcome for ivermectin in COVID-19 animal model

FDA expands approved indication for influenza treatment to include post-exposure prevention

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News